Susan D. de Jong

The Immunostimulatory Activity of Unmethylated and Methylated CpG Oligodeoxynucleotide Is Dependent on Their Ability To Colocalize with TLR9 in Late Endosomes

W. Jefferies, P. Cullis, Ying K. Tam, 2010, The Journal of Immunology.

Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy.

Ying K. Tam, Kaley D. Wilson, S. D. de Jong, 2009, Advanced drug delivery reviews.

Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.

P. Cullis, Ying K. Tam, L. Sekirov, 2009, International immunology.

The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN

P. Cullis, Ying K. Tam, L. Sekirov, 2008, Journal of drug targeting.

The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine

P. Cullis, M. Hope, Ying K. Tam, 2009, The journal of gene medicine.

The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine

P. Cullis, M. Hope, Ying K. Tam, 2009, The journal of gene medicine.

The Immunostimulatory Activity of Unmethylated and Methylated CpG Oligodeoxynucleotide Is Dependent on Their Ability To Colocalize with TLR9 in Late Endosomes

W. Jefferies, P. Cullis, Ying K. Tam, 2010, The Journal of Immunology.

Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy.

Ying K. Tam, Kaley D. Wilson, Susan D. de Jong, 2009, Advanced drug delivery reviews.